Barrett esophagus and life expectancy: implications for screening?
作者信息
Kuipers Ernst J
机构信息
Professor of Medicine Chair, Departments of Internal Medicine and Gastroenterology and Hepatology Erasmus MC University Medical Center Rotterdam, The Netherlands.
出版信息
Gastroenterol Hepatol (N Y). 2011 Oct;7(10):689-91.
Abstract
摘要
相似文献
1
Barrett esophagus and life expectancy: implications for screening?巴雷特食管与预期寿命：对筛查有何影响？
Gastroenterol Hepatol (N Y). 2011 Oct;7(10):689-91.
2
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.胃食管反流、巴雷特食管与食管癌：科学综述
JAMA. 2002 Apr 17;287(15):1972-81. doi: 10.1001/jama.287.15.1972.
3
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.高危人群中Barrett食管的筛查与监测：一项成本效益分析。
Ann Intern Med. 2003 Feb 4;138(3):176-86. doi: 10.7326/0003-4819-138-3-200302040-00009.
4
Barrett esophagus: an update.巴雷特食管：更新。
Nat Rev Gastroenterol Hepatol. 2010 Jul;7(7):369-78. doi: 10.1038/nrgastro.2010.78. Epub 2010 Jun 1.
5
Barrett esophagus.巴雷特食管
Curr Opin Gastroenterol. 2003 Jul;19(4):387-93. doi: 10.1097/00001574-200307000-00011.
6
Barrett esophagus.巴雷特食管
Curr Opin Gastroenterol. 2004 Jul;20(4):375-80. doi: 10.1097/00001574-200407000-00013.
7
Endoscopic management of Barrett esophagus.内镜下 Barrett 食管的处理。
Nat Rev Gastroenterol Hepatol. 2011 Sep 6;8(10):582-91. doi: 10.1038/nrgastro.2011.151.
8
Barrett esophagus.巴雷特食管
Curr Opin Gastroenterol. 2001 Jul;17(4):381-6. doi: 10.1097/00001574-200107000-00014.
9
Controversies in Barrett esophagus.巴雷特食管的争议
Mayo Clin Proc. 2014 Jul;89(7):973-84. doi: 10.1016/j.mayocp.2014.01.022. Epub 2014 May 24.
10
A clinical risk prediction model for Barrett esophagus. Barrett 食管的临床风险预测模型。
Cancer Prev Res (Phila). 2012 Sep;5(9):1115-23. doi: 10.1158/1940-6207.CAPR-12-0010. Epub 2012 Jul 11.
引用本文的文献
1
Diagnosis and treatment of patients with gastroesophageal reflux disease - a systematic review of cost-effectiveness and economic burden.胃食管反流病患者的诊断和治疗——成本效益和经济负担的系统评价。
BMC Health Serv Res. 2024 Nov 6;24(1):1351. doi: 10.1186/s12913-024-11781-8.
2
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.胃食管反流病患者发展为 Barrett 食管的长期风险因素：一项纵向队列研究。
BMJ Open Gastroenterol. 2024 Mar 22;11(1):e001307. doi: 10.1136/bmjgast-2023-001307.
3
Meta-analysis of Long-term De Novo Acid Reflux-Related Outcomes Following Sleeve Gastrectomy: Evidence Against the Need for Routine Postoperative Endoscopic Surveillance.袖状胃切除术后长期新发酸反流相关结局的荟萃分析：常规术后内镜监测无必要的证据。
Curr Obes Rep. 2023 Sep;12(3):395-405. doi: 10.1007/s13679-023-00521-4. Epub 2023 Aug 3.
4
Professionals' views on the justification for esophageal adenocarcinoma screening: A systematic literature search and qualitative analysis.专业人士对食管腺癌筛查合理性的看法：系统文献检索与定性分析
Prev Med Rep. 2023 May 26;34:102264. doi: 10.1016/j.pmedr.2023.102264. eCollection 2023 Aug.
5
Dietary approaches to stop hypertension (DASH)-style diet in association with gastroesophageal reflux disease in adolescents.青少年高血压膳食防治计划（DASH）饮食与胃食管反流病的相关性。
BMC Public Health. 2023 Feb 17;23(1):358. doi: 10.1186/s12889-023-15225-6.
6
Advanced Imaging for Barrett's Esophagus and Early Neoplasia: Surface and Subsurface Imaging for Diagnosis and Management.巴雷特食管和早期肿瘤的先进成像：用于诊断和管理的表面及亚表面成像
Curr Gastroenterol Rep. 2018 Oct 9;20(12):54. doi: 10.1007/s11894-018-0661-6.
本文引用的文献
1
The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.从 Barrett 食管发病到有症状的腺癌的最短潜伏期。
Br J Cancer. 2011 Jul 12;105(2):200-5. doi: 10.1038/bjc.2011.214. Epub 2011 Jun 14.
2
American Gastroenterological Association medical position statement on the management of Barrett's esophagus.美国胃肠病学会关于巴雷特食管管理的医学立场声明。
Gastroenterology. 2011 Mar;140(3):1084-91. doi: 10.1053/j.gastro.2011.01.030.
3
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.巴雷特食管患者发生恶性进展的风险：一项荷兰全国性队列研究。
Gut. 2010 Aug;59(8):1030-6. doi: 10.1136/gut.2009.176701.
4
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.巴雷特食管患者食管腺癌风险和死亡率的系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2010 Mar;8(3):235-44; quiz e32. doi: 10.1016/j.cgh.2009.10.010. Epub 2009 Oct 20.
5
Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.英国巴雷特食管的管理：治疗过度且活检不足，但一项全国性随机试验的开展使其情况得到改善。
Am J Gastroenterol. 2008 May;103(5):1079-89. doi: 10.1111/j.1572-0241.2008.01790.x. Epub 2008 Apr 28.
6
Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus.医疗事故史对巴雷特食管筛查与监测实践的影响。
Am J Gastroenterol. 2008 Apr;103(4):842-9. doi: 10.1111/j.1572-0241.2007.01689.x. Epub 2007 Dec 12.
7
Mortality rates in patients with Barrett's oesophagus.巴雷特食管患者的死亡率
Aliment Pharmacol Ther. 2008 Feb 15;27(4):316-20. doi: 10.1111/j.1365-2036.2007.03582.x. Epub 2007 Dec 6.
8
Risk of mortality and cancer incidence in Barrett's esophagus.巴雷特食管的死亡率和癌症发病率风险
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2090-6. doi: 10.1158/1055-9965.EPI-07-0432. Epub 2007 Sep 21.
9
Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?对巴雷特食管和食管腺癌进行筛查能延长生存期吗？
J Clin Oncol. 2005 Jul 10;23(20):4478-82. doi: 10.1200/JCO.2005.19.059.
Zotero 插件